ArticleInternational journal of microbiology2026
Determinants of Antimicrobial Resistance in
Article in International journal of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Determinants of Antimicrobial Resistance inInternational journal of microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: We conducted an integrated phenotypic-genotypic analysis of Results: We analysed 52 clinical isolates from 45 ICU patients. Multidrug resistance was nearly universal (98%), with complete resistance to carbapenems and fluoroquinolones and > 95% resistance to aminoglycosides and trimethoprim-sulfamethoxazole. Colistin activity was largely preserved, with resistance detected in only one isolate, despite widespread polymyxin resistance-associated mutations. Genotypic findings were mostly in line with the phenotypic results. All isolates belonged to the ST2 lineage, highlighting clonal homogeneity. No plasmid replicons were detected, suggesting chromosomal elements as the primary resistance drivers. Conclusions: Our first integrated dataset in an ICU setting from the Baltic region demonstrates alarming resistance levels and clonal dominance of ST2. Our findings highlight the importance of combining WGS with susceptibility testing for accurate resistance assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.